Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03846128
What this trial is testing

Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer

Who this might be right for
Metastatic Kidney Cancer
University Hospital, Rouen 6
Not applicableStudy completedNCT03211702
What this trial is testing

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonbuk National University Hospital 100
Not applicableStudy completedNCT03471741
What this trial is testing

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

Who this might be right for
Breast CancerRadiation Toxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Not applicableUnknownNCT05370729
What this trial is testing

Impact of N-acetylcysteine Infusion and Intralipid Infusion on Myocardial Injury in Aluminum Phosphide Toxicity

Who this might be right for
Myocardial Injury
Assiut University 58
Not applicableStudy completedNCT03429257
What this trial is testing

Maternal EED and Aflatoxin Birth Outcomes Study Uganda

Who this might be right for
Birth WeightPregnancy PretermAflatoxins Toxicity+1 more
Tufts University 258
Not applicableStudy completedNCT04816656
What this trial is testing

An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic

Who this might be right for
Covid19OncologyPROMs+1 more
Jessa Hospital 43
Testing effectiveness (Phase 2)Study completedNCT03081702
What this trial is testing

The Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian Cancer
University Health Network, Toronto 13
Not applicableStudy completedNCT02918695
What this trial is testing

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven 200
Not applicableNot Yet RecruitingNCT07733219
What this trial is testing

Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac

Who this might be right for
Ultracentral Pulmonary TumorsLung Cancer (T1 N0 M0 and T2 N0 M0)Mediastinal Lymph Node Recurrence From All Types of Primary Cancer+1 more
Centre Oscar Lambret 59
Not applicableStudy completedNCT07638904
What this trial is testing

Ozone Therapy for Cancer Therapy-Related Oral Mucositis

Who this might be right for
Oral Mucositis
University of Pavia 58
Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81
Testing effectiveness (Phase 2)Study completedNCT00003225
What this trial is testing

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 23
Not applicableStudy completedNCT04663178
What this trial is testing

Foot Bath and Chemotherapy Induced Fatigue

Who this might be right for
Chemotherapeutic ToxicityChemotherapy-induced Fatigue
Istanbul University - Cerrahpasa 75
Testing effectiveness (Phase 2)Study completedNCT00019227
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Who this might be right for
LymphomaRadiation Toxicity
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableStudy completedNCT03828942
What this trial is testing

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Who this might be right for
Hematological AbnormalityHematotoxicity
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableUnknownNCT06414343
What this trial is testing

LATe TreatmENT Related Toxicity in Melanoma (LATENT)

Who this might be right for
Melanoma
Royal Marsden NHS Foundation Trust 400
Not applicableNot Yet RecruitingNCT05377320
What this trial is testing

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Who this might be right for
Heart FailureCoronary Artery DiseasePeripheral Artery Disease+5 more
Medical College of Wisconsin 60
Large-scale testing (Phase 3)UnknownNCT05001074
What this trial is testing

Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients

Who this might be right for
Lung Transplant; Complications
Heleen Grootjans 145
Not applicableStudy completedNCT05886335
What this trial is testing

Influence of Timing PTCy in AlloSCT

Who this might be right for
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180
Next Page